Role of depressive symptoms in cardiometabolic diseases and subsequent transitions to all-cause mortality: an application of multistate models in a prospective cohort study.

作者: Chaofu Ke , Yanan Qiao , Siyuan Liu , Ying Wu , Yi Ding

DOI: 10.1136/SVN-2020-000693

关键词:

摘要: Background and purpose The role of depression in the development outcome cardiometabolic diseases remains to be clarified. We aimed examine extent which depressive symptoms affect transitions from healthy diabetes, stroke, heart disease subsequent all-cause mortality a middle-aged elderly European population. Methods A total 78 212 individuals aged ≥50 years Survey Health Ageing Retirement Europe were included. Participants with any baseline including stroke excluded. Depressive measured by Euro-Depression scale at baseline. followed up determine occurrence mortality. used multistate models estimate transition-specific HRs 95% CIs after adjustment confounders. Results During 500 711 person-years follow-up, 4742 participants developed 2173 had 5487 7182 died. significantly associated diabetes (HR: 1.12, CI: 1.05 1.20), 1.31, 1.18 1.44), 1.26, 1.34) 1.41, 1.34 1.49). After diseases, increased risk patients 1.54, 1.25 1.89), who 1.29, 1.03 1.61) 1.21, 1.02 1.44). Conclusions increase disease, onset these conditions. Screening treatment may have profound implications for prevention prognosis diseases.

参考文章(36)
A. Alwan, Global status report on noncommunicable diseases 2010. Global status report on noncommunicable diseases 2010.. ,(2011)
Liesbeth C. de Wreede, Marta Fiocco, Hein Putter, mstate: An R Package for the Analysis of Competing Risks and Multi-State Models Journal of Statistical Software. ,vol. 38, pp. 1- 30 ,(2011) , 10.18637/JSS.V038.I07
E.Sherwood Brown, Femina P Varghese, Bruce S McEwen, Association of depression with medical illness: does cortisol play a role? Biological Psychiatry. ,vol. 55, pp. 1- 9 ,(2004) , 10.1016/S0006-3223(03)00473-6
P. G. Surtees, N.W.J. Wainwright, R. N. Luben, N. J. Wareham, S. A. Bingham, K.-T Khaw, Psychological distress, major depressive disorder, and risk of stroke Neurology. ,vol. 70, pp. 788- 794 ,(2008) , 10.1212/01.WNL.0000304109.18563.81
M. J. Prince, F. Reischies, A. T. F. Beekman, R. Fuhrer, C. Jonker, S. -L. Kivela, B. A. Lawlor, A. Lobo, H. Magnusson, M. Fichter, H. Van Oyen, M. Roelands, I. Skoog, C. Turrina, J. R. M. Copeland, Development of the EURO-D scale--a European, Union initiative to compare symptoms of depression in 14 European centres. British Journal of Psychiatry. ,vol. 174, pp. 330- 338 ,(1999) , 10.1192/BJP.174.4.330
Jussi Jokinen, Peter Nordström, HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients Journal of Affective Disorders. ,vol. 116, pp. 88- 92 ,(2009) , 10.1016/J.JAD.2008.10.025
Charles Ellis, Yumin Zhao, Leonard E. Egede, Depression and increased risk of death in adults with stroke. Journal of Psychosomatic Research. ,vol. 68, pp. 545- 551 ,(2010) , 10.1016/J.JPSYCHORES.2009.11.006
Aruna D Pradhan, JoAnn E Manson, Nader Rifai, Julie E Buring, Paul M Ridker, None, C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus JAMA. ,vol. 286, pp. 327- 334 ,(2001) , 10.1001/JAMA.286.3.327
Fabrice Bonnet, Kate Irving, Jean-Louis Terra, Patrice Nony, François Berthezène, Philippe Moulin, Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease Atherosclerosis. ,vol. 178, pp. 339- 344 ,(2005) , 10.1016/J.ATHEROSCLEROSIS.2004.08.035